当前位置: 首页 > 期刊 > 《中国医学创新》 > 2011年第29期
编号:13186622
尿微量白蛋白对心梗患者预后评价分析(2)
http://www.100md.com 2011年10月15日 王燕 刘惠敏 冯虎
第1页

    参见附件。

     [6] Kistorp C, Raymond L, Pedersen F, et al. N-teminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA, 2005,293:1609-1616.

    [7] Luft FC, Agrawal B. Microalbuminuria as a predictive factor for cardiovaseular events. J Cardiovascular Pharnaacol, 1999,33(suppl1):s11-s15.

    [8] Kuusisto J, Mykkanen L, Pyorala K, et al. Hyperinsulinemic mieroalbuminuria: a new risk indicator for coronary heart disease. Circulation, 1995,91:831-837.

    [9] Viberti GC, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation, 2002,106(6):672-678.

    [10] Hasdai D, Holmes DR Jr, Calif RM, et al. Cardiogenic shock complicating acute myocardial infarction: predictom of death. The GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occlude comonary arteries. Am Heart J, 1999,138:368-684.

    [11] Berton G, Cordiano R, Mazzuco S,et al. Albumin excretion in acute myocardial infarction: a guide for long-term prognosis. Am Heart J, 2008,156:760-768.

    (收稿日期:2011-07-20)

    (本文编辑:郎威)

您现在查看是摘要介绍页,详见PDF附件